Aurobindo Pharma | ARBP - Cost Of Sales

Stock Price
1,338.90
Daily Change
3.80 0.28%
Monthly
4.13%
Yearly
23.68%
Q2 Forecast
1,306.83

Aurobindo Pharma reported INR39.46B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Cipla INR 29.1B 1.16B Dec/2025
Divis Laboratories Ltd INR 10.63B 1.23B Dec/2025
Dr.Reddys Laboratories INR 36.16B 3.75B Dec/2025
Hindustan Unilever INR 83.28B 770M Dec/2025
Sun Pharmaceuticals INR 36.77B 348M Dec/2025
UPL INR 66.73B 1.49B Dec/2025